Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly. Wet AMD includes typical choroidal neovascularization (CNV) and polypoidal choroidal vasculopathy (PCV). The etiology and pathogenesis of CNV and PCV are not well understood. Genome-wide association studies have linked a multifunctional serine protease, HTRA1, to AMD. However, the precise role of HTRA1 in AMD remains elusive. By transgenically expressing human HTRA1 in mouse retinal pigment epithelium, we showed that increased HTRA1 induced cardinal features of PCV, including branching networks of choroidal vessels, polypoidal lesions, severe degeneration of the elastic laminae, and tunica media of choroidal vessels. In addition, HTRA1 mice displayed retinal pigment epithelium atrophy and photoreceptor degeneration. Senescent HTRA1 mice developed occult CNV, which likely resulted from the degradation of the elastic lamina of Bruch's membrane and up-regulation of VEGF. Our results indicate that increased HTRA1 is sufficient to cause PCV and is a significant risk factor for CNV.
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly. Wet AMD includes typical choroidal neovascularization (CNV) and polypoidal choroidal vasculopathy (PCV). The etiology and pathogenesis of CNV and PCV are not well understood. Genome-wide association studies have linked a multifunctional serine protease, HTRA1, to AMD. However, the precise role of HTRA1 in AMD remains elusive. By transgenically expressing human HTRA1 in mouse retinal pigment epithelium, we showed that increased HTRA1 induced cardinal features of PCV, including branching networks of choroidal vessels, polypoidal lesions, severe degeneration of the elastic laminae, and tunica media of choroidal vessels. In addition, HTRA1 mice displayed retinal pigment epithelium atrophy and photoreceptor degeneration. Senescent HTRA1 mice developed occult CNV, which likely resulted from the degradation of the elastic lamina of Bruch's membrane and up-regulation of VEGF. Our results indicate that increased HTRA1 is sufficient to cause PCV and is a significant risk factor for CNV.
A dvanced age-related macular degeneration (AMD) can be classified into wet AMD and geographic atrophy (1, 2) . Wet AMD includes the typical choroidal neovascularization (CNV) and polypoidal choroidal vasculopathy (PCV). CNV is caused by the growth of new blood vessels from the choroid into the subretinal pigment epithelium (RPE) and subretinal spaces, whereas PCV is caused by inner choroidal vessel abnormalities (3) . PCV has two key features on indocyanine green angiography (ICGA): polypoidal vascular dilations and a network of branching abnormal choroid vessels (4) . Both CNV and PCV can lead to recurrent serous exudation and hemorrhages (5) . The etiology and pathogenesis of CNV and PCV are largely unknown.
Numerous genetic association studies have shown that chromosome 10q26 is a major candidate region associated with the susceptibility of several types of AMD (6, 7) , including PCV (8) (9) (10) . The linkage peak was refined to two neighboring genes, HTRA1 (11, 12) and ARMS2 (or LOC387715) (13) . HTRA1 is a multifunctional serine protease that is ubiquitously expressed in mammalian tissues (14, 15) but ARMS2 is primate-specific, with a proposed function in mitochondria (13, 16) , extracellular matrix (17) , or as a noncoding RNA (18) . Variants in this region are in strong linkage disequilibrium (11) (12) (13) 16 ). There are three major competing hypotheses attributing increased risk of AMD to (i) increased HTRA1 (11, 12) , (ii) decreased ARMS2 (16), or (iii) both increased HTRA1 and decreased ARMS2 (19) . However, a series of studies on the influence of AMD-associated polymorphisms on the expression of ARMS2 and HTRA1 have yielded widely conflicting results (12, 16, (18) (19) (20) (21) (22) (23) (24) . As a result, the functional involvement of either HTRA1 or ARMS2 in AMD remains uncertain, despite strong genetic evidence (18, 22) . To clarify the role of HTRA1 in AMD pathogenesis, we transgenically expressed human HTRA1 in mouse RPE. We showed that increased HTRA1 is sufficient to cause PCV and occult CNV, two types of wet AMD.
Results
Expression of Human HTRA1 in Mouse RPE. We generated a mouse line (hHTRA1 + ) overexpressing human HTRA1 (hHTRA1) in mouse RPE. The transgene was driven by a hybrid promoter consisting of the human cytomegalovirus immediate-early enhancer/promoter (CMV-IE) and the RPE-specific human vitelliform macular dystrophy 2 (VMD2) promoter (25) . When used with a cellular promoter, the CMV-IE was shown to enhance the expression of transgenes (26) (27) (28) . Human HTRA1 was specifically expressed in mouse RPE, as determined by real-time RT-PCR (Fig. 1A) . Because we added a myc-His 6 tag at the C terminal of human HTRA1, we detected the expression of transgenic HTRA1 in hHTRA1 + RPE by Western blotting with anti-myc antibody 9E10 (Fig. 1B, Upper) . The absolute levels of human HTRA1 in transgenic hHTRA1 + and normal human (ages between 50 and 60 y old) RPE were measured by Western blotting with a monoclonal antibody that recognizes human but not mouse HTRA1. By comparing with purified (His) 6 -tagged recombinant human HTRA1 standards, the human HTRA1 level was determined to be 2.96 ± 0.56 ng/15 μg lysate in hHTRA1 + RPE, which was 5.3-times that of human RPE (0.56 ± 0.09 ng/15 μg lysate) ( Fig. 1 C-E) . By immunohistochemistry, human HTRA1 was located in the RPE of hHTRA1 + mouse (Fig. 1F , Lower, green signals). Consistent with its role as a secreted protein functioning in the extracellular matrix (29, 30) , we observed signals at the basal side of RPE (Fig. 1F , Lower, arrows), the Bruch's membrane, and the choroid of hHTRA1 + mice, suggesting that transgenic HTRA1 was secreted from the basal RPE toward Bruch's membrane/choroid. This pattern is similar to endogenous HTRA1 expression in human eyes (SI Appendix, Fig. S1 ). (Fig. 1B) . The genetic background of hHTRA1 + mice appeared to have an impact on phenotype progression because 78% of progenies from PCV + parents developed PCV, in contrast to 28% from PCV − parents. In the PCV + mice, there was a broad phenotypic spectrum ranging from weak to severe (SI Appendix, Fig. S2C ). The lesions were rarely visible on fluorescein angiography (FA), which is more suitable to image retinal vasculature, and were best seen on ICGA, which is more suitable to image posterior choroidal vasculature because of its infrared spectrum ( Fig. 2 A, B, and D) . The ICGA lesions were located in the choroid by spectral domain optical coherence tomography (SD-OCT) (SI Appendix, Fig. S3 ). On ocular fundus examination, hHTRA1 + mice showed prominent orange-yellow lesions ( Fig. 2A, red circles) , many of which appeared to have the same locations as ICGA lesions. In senescent hHTRA1 + mice (older than 11 mo), we could see speckled hyperfluorescence with poorly demarcated leakage in late-phase FA, which resembles occult CNV, in four of eight PCV + mice (Fig. 2C, circles) . The same was not observed in either the PCV − (n = 3) or WT littermates (n = 2). The occurrence of occult CNV was not correlated with the severity of PCV (SI Appendix, Table S1 ), suggesting different factors are involved in controlling the progression of the two types of wet AMD.
Degradation of the Elastic Lamina of the Bruch's Membrane and Choroidal Vessels in hHTRA1 + Mice. The PCV lesions in hHTRA1 + mice likely resulted from the exudates of compromised choroidal vessels (Fig. 3) . Indeed, pools of blood cells in the sub-RPE space were frequently present in the hHTRA1 + mice (Fig. 3A , yellow arrows, quantification shown at the bottom of Fig. 3 ), apparently from hemorrhagic choroidal vessels. In contrast to the normal choroidal architecture of WT mice, the hHTRA1 + mice (11 mo old) contained clusters of abnormally dilated, thin-wall vessels beneath the RPE (Fig. 3B , arrows, quantification shown at the bottom of the figure). These features were similar to histopathologic findings on surgically excised human PCV specimens A B 6 -tagged recombinant human HTRA1 protein (∼52 kDa) was used as standards (in nanograms). The myc-His 6 tagged transgenic HTRA1, (His) 6 -tagged recombinant HTRA1, and native HTRA1 (from human RPE) ran at 55, 52, and 50 kDa, respectively. (D) The pixel values of the recombinant protein bands in C in arbitrary units (AU) were plotted against the protein amounts to construct a standard curve. The expression levels of human HTRA1 in hHTRA1 + and human RPE were determined according to their AU and the standard curve. (E) Comparison of human HTRA1 protein levels in hHTRA1 + and human RPE (n = 6). ***P < 0.001. (F) Retinal sections from WT and hHTRA1 + mice immunostained with a mouse anti-human HTRA1 antibody (green). Transgenic HTRA1 was detected in the basal side of RPE (red arrows), the choroid, and the Bruch's membrane. The cross reactivity of HTRA1 antibody with the Bruch's membrane (SI Appendix, (32, 33). Consistent with histological findings (Fig. 3 A and B) , ultrastructural analysis of 11-mo-old hHTRA1 + mice showed marked attenuation of the choroidal vessels (Fig. 3C, Right) . The choroidal arteries in atrophic regions completely lacked both the elastic interna and elastic externa. The tunica media was severely degenerated or missing. In sharp contrast, the neighboring retinal vessels were normal in hHTRA1 + mice (SI Appendix, Fig. S4 ), which is consistent with the normal FA ( Fig. 2A) , and the immunohistochemical results showing HTRA1 was secreted from the basal RPE toward the choroid side (Fig. 1F) .
Another prominent feature of the hHTRA1 + -PCV + mice was that the integrity of the elastic lamina (EL) of the Bruch's membrane was severely compromised (64.3% vs. 94.8% in WT; EL integrity was defined as the total length of EL divided by the total length of Bruch's membrane in a given region) ( Table 1) . The EL of the PCV + mice was fragmented, and interrupted by gaps of varying sizes (Fig. 4A, Lower, brackets) . The degradation of EL shares close similarity to macular EL disruption associated with AMD lesions (34) . The length of the longest uninterrupted EL was only 9.9 μm in hHTRA1 + mice compared with 32.9 μm in WT ( Table 1 ). The combined gap length was ∼nine-times larger in PCV + mice than that in WT (318.55 vs. 36.32 μm). It is interesting that the largest gap length in PCV + mice, ∼8 μm, was close to the average gap length (∼9-10 μm) in the macula of AMD patients (34) . Not surprisingly, we observed choroidal endothelial processes inserting into the EL gaps of PCV + mice (Fig. 4B, Middle Right, red arrowheads) , supporting the notion that the breakdown of Bruch's membrane allows the invasion of choroid vessels into the RPE (35) . In both the inner and outer collagenous layers of the Bruch's membrane, there were membrane-bound basal linear deposits (Fig. 4B , Bottom Right, red arrows), which were linked to early AMD (36) . Despite the extensive degeneration of the EL, the collagen fibers in both the inner collagenous layer and outer collagenous layer, and the basement membranes of both the RPE and the choriocapillaris, appear to be normal in most regions (SI Appendix, Fig. S5 ). RPE cells from PCV + mice had normal polygonal morphology, as revealed by Alexa 488-phalloidin staining (SI Appendix, Fig. S6 ).
Besides lesions in the choroid and Bruch's membrane, hHTRA1 + -PCV + mice showed degenerative changes in the RPE and photoreceptors. There were vacuoles in the RPE (Fig. 4B , Bottom, with quantification), some of which were filled with vesicular materials (Fig. 4B , Bottom Left, yellow arrows) but others were empty (Fig. 4B, Bottom Right, yellow arrowheads) . In some areas, RPE was devoid of basal infoldings (Fig. 4B , Middle Left, red brackets). Areas of RPE hypopigmentation (Fig. 3A , black arrows) and hyperpigmentation (Fig. 4B , Middle) were evident in hHTRA1 + -PCV + mice. Both the outer and inner segments of hHTRA1 + -PCV + mice were disorganized, with marked vacuolization in the inner segment (Fig. 4C , Right, red arrows and arrowheads indicate vacuoles between and within the inner segment, respectively). In contrast to PCV + mice, hHTRA1 + -PCV − mice had significantly better EL integrity, normal structures of choroid vessels, RPE, and photoreceptors (Table 1 , and SI Appendix, Fig. S7 ).
HTRA1 Exhibits Elastase Activity. The most parsimonious explanation for the elastin degradation in both the Bruch's membrane and the choroid vessels in the hHTRA1 + mice is that the protease activity of overexpressed HTRA1, which is secreted from RPE, caused the degeneration. Because HTRA1 was not known to have elastase activity, we performed an in vitro elastin degradation assay using DQ elastin, a soluble elastin labeled with quenched BODIPY FL dye, as a substrate (Fig. 5A) . Purified recombinant human HTRA1 can degrade elastin with a specific activity of 4.4 ± 0.8 μ/mg (n = 3). This activity was ∼30-times less than that of porcine pancreas elastase (135 ± 5.5 μ/mg, n = 4), suggesting that the basal elastase activity of HTRA1 was low. To eliminate the possibility that the degeneration of the elastic layers of the choroidal vessels and Bruch's membrane was the result of down-regulation of elastin expression, we analyzed the protein level of soluble elastin in the RPE/choroid of hHTRA1 + and WT mice by Western blot. The level of tropoelastin, the soluble precursor of elastin, was similar in both the hHTRA1 + mice and WT (Fig. 5B) , suggesting that the biosynthesis of elastin is not altered by HTRA1 overexpression. However, there is an increase of degraded elastin products (Fig. 5B, bracket Bruch's membrane and the choroid vessels in PCV + mice (see more in Discussion).
Increased VEGF in hHTRA1 + Mice. VEGF plays a significant role in the progression of CNV (37), although its role in PCV is controversial (32, 33, 38, 39) . We examined the expression of VEGF in the RPE/ choroid of hHTRA1 + mice by Western blotting (Fig. 6A ) and immunohistochemistry (Fig. 6B) . Compared with WT, the VEGF level was increased in both PCV + and PCV − mice (Fig. 6A ). Our data suggest that (i) increased HTRA1 can lead to up-regulation of VEGF in the RPE/choroid of hHTRA1 + mice, and (ii) VEGF elevation is not sufficient to induce PCV although it is critical for CNV pathogenesis (see Discussion). Our results explain the limited effect of anti-VEGF therapy in treating PCV (40) (41) (42) (43) .
Human HTRA1 Alone Was Sufficient to Cause PCV. Because hHTRA1 + mice expressed both mouse and human HTRA1 in their RPE, we explored whether overexpression of human HTRA1 alone was sufficient to cause PCV by breeding hHTRA1 + mice into the Htra1 −/− background (SI Appendix, Fig. S8 A-E). Consistent with findings on CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) patients with reduced or no HTRA1 protein (44), we did not find any PCV or CNV features in Htra1 −/− mice determined by histology, FA, ICGA, and SD-OCT (SI Appendix, Fig. S8 F and G) . However, overexpression of human HTRA1 in the RPE of Htra1 −/− mice resulted in PCV features similar to those in hHTRA1 Fig. S9, Right) . This result is significant in terms of designing new therapeutic interventions for AMD: it suggests that clinicians can safely target HTRA1 in the eye by local delivery of reagents (e.g., shRNA/siRNA).
Discussion
By overexpressing human HTRA1 in mouse RPE, we showed that increased HTRA1 leads to PCV and occult CNV in mice. The lesions in both the Bruch's membrane and the choroidal vessels were likely caused by the elastase activity of overexpressed HTRA1 (Fig. 5A) . The low basal elastase activity of HTRA1 is consistent with biochemical studies showing that both the N-terminal Kazal-type serine-protease inhibitor domain and the C-terminal PDZ domain regulate HTRA1 activity (45, 46) . It suggests that extracellular matrix proteins are likely involved in activating HTRA1 and producing the PCV phenotype, probably by interacting with the PDZ domain and the inhibitor domain. It was shown that the removal of the inhibitor domain or binding of PDZ domain activates HTRA1 protease activity ∼threefold (with a combined effect of >ninefold) (46) . This result may explain the wide phenotypic variations in hHTRA1 + mice. However, it should be mentioned that HTRA1 is a complex protein containing a homology domain to Mac25 and insulin-like growthfactor binding proteins, a Kazal-type inhibitor motif, the protease domain, and the PDZ domain, all of which may contribute to the phenotypes we observed. Future work in generating transgenic mice expressing the protease-inactive form of HTRA1, as well as HTRA1 lacking various domains, should help clarify the biochemical mechanism on how increased HTRA1 leads to PCV and occult CNV.
To estimate the percentage of HTRA1 secreted from RPE, we compared the endogenous HTRA1 level in the supernatant versus the lysate of the human RPE cell line, ARPE-19. Approximately 43% of HTRA1 was secreted into the supernatant (SI Appendix, Fig. S10 and SI Materials and Methods). It is likely that a significant amount of human HTRA1 remains inside the RPE of hHTRA1 + mice. The exact role of intracellular HTRA1 is unclear because hHTRA1 + mice exhibit most prominent phenotypes in the extracellular space of RPE (i.e., Bruch's membrane and choroid). It is worth mentioning that the endogenous HTRA1 is ubiquitously expressed in vertebrates (14, 15) . Overexpressing HTRA1 in mouse RPE may have expedited the development of PCV phenotype. However, it may also cause unintended damage to the target tissue (e.g., RPE lesions), although hHTRA1 + mice exhibit phenotypes that closely resemble human PCV.
Why is the degeneration of the choroid vessels much more severe than that of the Bruch's membrane (Figs. 3C vs. 4A) that is closer to the RPE? One possible explanation is that the Bruch's membrane acts as a physical barrier for cells mediating inflammatory responses (i.e., leukocytes, lymphocytes, and macrophages), therefore mitigating the possible damaging effect by secondary immune responses (35) . Indeed, we found that the basement membranes of both the RPE and the choriocapillaris and the collagen fibers in the Bruch's membrane were normal in most regions, despite the EL degeneration (SI Appendix, Fig. S5 ). In contrast, the tunica adventitia, which contains large amount of collagen fibers, and the tunica media, which is composed predominantly of smooth muscle, were severely degenerated in choroid arteries in addition to the degradation of the elastic lamina (Fig. 3C) , suggesting that inflammatory processes (involving T cells, macrophages, matrix metalloproteinases, neutrophil elastase, and so forth) likely participated in the degradation of choroid vessel walls following the initial "assault" by HTRA1.
As in human PCV patients, we did not observe drusen in hHTRA1 + mice. Although hHTRA1 + mice exhibit robust features of PCV, there is no classic CNV formation, suggesting that additional factors, such as oxidative stress, complement activation (2), may be required to develop typical CNV. The other possible explanation is the relative intactness of the basement membranes and collagenous fibers in the Bruch's membrane. Nevertheless, increased HTRA1 led to the degradation of the EL of Bruch's membrane (Fig. 4A and Table 1 ) and up-regulation of VEGF (Fig. 6) , both of which are risk factors for CNV (34, 37) . Our result is consistent with a recent study showing that the vitreous level of HtrA1 was significantly associated with that of VEGF in patients with eye diseases (ocular vascular diseases, retinal detachment, idiopathic macular hole, and traumatic injury) (47) . Both HTRA1 and VEGF were up-regulated in human fetal RPE cells under stress conditions (47) . In HTRA1 mice, VEGF may be up-regulated in response to the RPE stress induced by HTRA1 overexpression. Future studies are necessary to elucidate the exact mechanism of VEGF regulation in hHTRA1 + transgenic mice. Because both the integrity and thickness of the EL in the macula are significantly decreased compared with the extramacular region (34) , HTRA1 may be a key molecule predisposing the human macula to wet AMD. The degradation of the elastic lamina in both the Bruch's membrane and the choroid vessels of HTRA1 mice is particularly intriguing considering multiple lines of evidence suggesting a relationship between increased elastin degradation and the progression of wet AMD. For example, serum levels of elastin-derived peptides in patients with exudative AMD are significantly higher than those in nonexudative AMD patients and control patients (48) . Decreased integrity of the macular EL is strongly correlated with early AMD and CNV (34) . Collectively, our data show that increased HTRA1 is sufficient to cause PCV and is a significant risk factor for CNV. It suggests that ARMS2 is unlikely to play a major role in PCV pathogenesis. This is likely to be the case for CNV pathogenesis as well because PCV and CNV are genetically similar in the 10q26 loci (10) . The role of HTRA1 in wet AMD is supported by recent studies showing that genetic variants at HTRA1-ARMS2 loci are significantly associated with lesion sizes in both PCV and CNV patients (49, 50) , and confer a higher risk of CNV than geographic atrophy in a well-powered sample (51) . In contrast, there is no functional evidence to date that ARMS2 plays any angiogenic role related to CNV or PCV.
Finally, we found that the genetic background of hHTRA1 + mice had a strong influence on the phenotype. Currently, there is no effective pharmacological treatment for PCV. Designing HTRA1-specific inhibitors and determining HTRA1 modulating 
